Sanofi, GSK restart trials on COVID-19 vaccine after delay ...United Arab Emirates

Sanofi and GlaxoSmithKline Plc are restarting a trial of their COVID-19 vaccine, a step forward for a shot that got delayed by a problematic study in the fall. The French drugmaker has corrected the formulation of the shot, which was weaker than planned in the previous trial and failed to create enough of an immune response in people 50 years and older, according to a statement Monday. Assuming results are good for the new second-phase trial - which will include 720 adults in the US, Honduras and Panama - the candidate could move on to late-stage studies in the second quarter and become available by the end of the year. The current trial will evaluate three different dosages for the vaccine

Hence then, the article about sanofi gsk restart trials on covid 19 vaccine after delay was published today ( Sunday 28/02/2021 - 07:31 PM ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi, GSK restart trials on COVID-19 vaccine after delay )

Also on site :

• Ukraine-Russia war latest: Zelensky awaits Putin response to new peace plan while Christmas Eve blast kills 3 in Moscow
• JCPenney Has a 'Stunning' White Sapphire Jewelry Set on Sale for Just $16, and It's Perfect for Every Occasion
• ‘Adopt-a-Grandparent’: DJ’s Christmas event reminds nursing home residents that somebody cares